Document:

Exhibit 10.2

                                  Exhibit 10.2

$3,225,000.00                                                   OCTOBER 18, 2000

          FOR VALUE RECEIVED, SURGILIGHT, INC. (the "Borrower"), unconditionally
promises to pay to PREMIER LASER SYSTEMS, INC. (the "Lender") a total of
$3,225,000.00 (the "Original Principal") in the manner and at the place
hereinafter provided on the following dates:

          (1) On December 15, 2000, $1,000,000.00;

          (2) On January 15, 2001, $1,000,000.00;

          (3) On February 15, 2001, $725,000.00;

          (4) On February 28, 2001, $500,000.00.

          Section 1. Payments. All payments in respect of this Note shall be
made by wire transfer per the Wire Transfer Instructions attached hereto as
Exhibit 1. Whenever any payment on this Note is stated to be due on a day that
is not a Business Day, such payment shall instead be made on the next Business
Day, and such extension of time shall be included in the computation of interest
payable on this Note. "Business Day" means any day other than a Saturday, Sunday
or legal holiday under the laws of the State of California or any other day on
which banking institutions located in such state are authorized or required by
law or other governmental action to close.

          Section 2. Voluntary Prepayments. The Borrower shall have the right at
any time and from time to time to prepay the principal of this Note in whole or
in part, without premium or penalty.

          Section 3. Mandatory Prepayments. The outstanding principal amount
under this Note shall be prepaid from the proceeds of any sale, assignment, or
transfer for value of the Collateral (as defined in the Pledge and Security
Agreement (the "Pledge Agreement") dated as of the date hereof by and between
Borrower and Lender), except for the proceeds of the sale of inventory in the
ordinary course of business as provided for in Section 7 of the Pledge
Agreement. Not later than the business day after the proceeds are received by
Borrower, the Borrower shall pay to the Lender the lesser of (i) the amount of
such proceeds or (ii) the unpaid principal amount under this Note made by the
Lender to the Borrower hereunder and any accrued, unpaid interest thereon.

          Section 4. Interest. In the event that Borrower has failed to pay the
full amount of the Original Principal by March 1, 2001, the Borrower promises to
pay, in addition to the unpaid principal, interest on the unpaid principal
amount thereof from the date on which the Event of Default resulting from
Borrower's failure to pay such principal under this Note occurred until paid in
full at a rate equal to ten percent (10.0%) per annum. All computations of
interest shall be made by the Lender on the basis of a 365 day year, for the
actual number of days elapsed in the relevant period (including the first day
but excluding the last day). In no event shall the interest rate payable on this
Note exceed the maximum rate of interest permitted to be charged under
applicable law.

                                       1

<PAGE>

          Section 5. Events of Default. The occurrence of any of the following
events shall constitute an "Event of Default":

          (a) failure of the Borrower to pay any principal under this Note when
     due, whether at stated maturity, declaration, acceleration, demand,
     mandatory prepayment or otherwise;

          (b) a default by Borrower under (i) the Purchase Agreement dated as of
     September 23, 2000 by and between Borrower and Lender, (ii) the Patent
     Assignment and License Agreement dated as of October 18, 2000 by and
     between Borrower and Lender, or (iii) the Pledge Agreement.

          (c) (i) a court having jurisdiction in the premises shall enter a
     decree or order for relief in respect of the Borrower in an involuntary
     case under Title 11 of the United States Code entitled "Bankruptcy" (as now
     and hereinafter in effect, or any successor thereto, the "Bankruptcy Code")
     or any applicable bankruptcy, insolvency or other similar law now or
     hereafter in effect, which decree or order is not stayed; or any other
     similar relief shall be granted under any applicable federal or state law;
     or (ii) an involuntary case shall be commenced against the Borrower under
     any applicable bankruptcy, insolvency or other similar law now or hereafter
     in effect; or a decree or order of a court having jurisdiction in the
     premises for the appointment of a receiver, liquidator, sequestrator,
     trustee, custodian or other officer having similar powers over the Borrower
     or over all or a substantial part of its property shall have been entered;
     or the involuntary appointment of an interim receiver, trustee or other
     custodian of the Borrower for all or a substantial part of its property
     shall have occurred; or a warrant of attachment, execution or similar
     process shall have been issued against any substantial part of the property
     of the Borrower, and, in the case of any event described in this clause
     (ii), such event shall have continued for 90 days unless dismissed, bonded
     or discharged; or

          (d) an order for relief shall be entered with respect to the Borrower
     or the Borrower shall commence a voluntary case under the Bankruptcy Code
     or any applicable bankruptcy, insolvency or other similar law now or
     hereafter in effect, or shall consent to the entry of an order for relief
     in an involuntary case, or to the conversion of an involuntary case to a
     voluntary case, under any such law, or shall consent to the appointment of
     or taking possession by a receiver, trustee or other custodian for all or a
     substantial part of its property; or the Borrower shall make an assignment
     for the benefit of creditors; or

          Section 6. Remedies. Upon the occurrence of any Event of Default
specified above, the outstanding principal amount of this Note shall become
immediately due and payable, without presentment, demand, notice, protest or
other requirements of any kind (all of which are hereby expressly waived by the
Borrower).

                                       2

<PAGE>

          Section 7. Miscellaneous.

          (a) All notices and other communications provided for hereunder shall
be in writing (including telegraphic, telex, telefacsimile or cable
communication) and mailed, telegraphed, telexed, telecopied, cabled or delivered
as follows: if to the Borrower, at its address specified opposite the Borrower's
signature below; and if to the Lender, at the address specified in Section 2
hereof, or in each case at such other address as shall be designated by the
Lender or the Borrower. All such notices and communications shall, when mailed,
telegraphed, telexed, telecopied or cabled or sent by overnight courier, be
effective when deposited in the mails, delivered to the telegraph company, cable
company or overnight courier, as the case may be, or sent by telex or
telecopier.

          (b) The Borrower promises to pay all costs and expenses, including
     reasonable attorney's fees, incurred in connection with any modification of
     this Note or any collection and enforcement of this Note.

          (c) No failure or delay on the part of the Lender to exercise any
     right, power or privilege under this Note shall impair such right, power or
     privilege or operate as a waiver of any default or an acquiescence therein,
     nor shall any single or partial exercise of any such right, power or
     privilege preclude any other or further exercise thereof or the exercise of
     any other right, power or privilege. The rights and remedies expressly
     provided in this Note are cumulative to, and not exclusive of, any rights
     or remedies that the Lender would otherwise have.

          (d) The Borrower hereby consents to renewals and extensions of time at
     or after the maturity of this Note, without notice, and hereby waives
     diligence, presentment, protest, demand and notice of every kind and, to
     the full extent permitted by law.

          (e) If any provision in or obligation under this Note shall be
     invalid, illegal or unenforceable in any jurisdiction, the validity,
     legality and enforceability of the remaining provisions or obligations, or
     of such provision or obligation in any other jurisdiction, shall not in any
     way be affected or impaired thereby.

          (f) This Note shall be binding upon the Borrower and the Lender and
     their respective successors and assigns. None of the terms or provisions of
     this Note may be waived, altered, modified or amended except in writing
     duly signed for and on behalf of the Lender and the Borrower. This Note may
     not be assigned by either party without the prior written consent of the
     other party.

          THIS NOTE AND THE RIGHTS AND OBLIGATIONS OF THE BORROWER AND THE
LENDER HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN
ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD TO
CONFLICTS OF LAWS PRINCIPLES.

                                       3

<PAGE>

          IN WITNESS WHEREOF, The Borrower has caused this Note to be executed
and delivered as of the day and year first above written.

                                            SURGILIGHT, INC.

                                            By:  /s/  J.T. Lin
                                               ------------------------------
                                                      J.T. Lin, President and
                                                      Chief Executive Officer,
                                                      SurgiLight, Inc.

                                            SurgiLight, Inc.
                                            12001 Science Drive, Suite 140
                                            Orland, Florida 32826

                                       4Exhibit 10.3

                                  Exhibit 10.3

                     PATENT ASSIGNMENT AND LICENSE AGREEMENT
                     ---------------------------------------

     THIS PATENT ASSIGNMENT AND LICENSE AGREEMENT ("Agreement") is entered into
and effective this 18th day of October, 2000, by and between Premier Laser
Systems, Inc., a California corporation ("SELLER") and Surgilight, Inc., a
Delaware corporation ("BUYER").

                                    RECITALS
                                    --------

     A. SELLER is the owner of certain patents and patent applications relating
to ophthalmic devices and/or methods, defined below as the Assigned Patents and
Licensed Patents.

     B. BUYER desires to obtain an assignment of the Assigned Patents, and to
obtain a limited, worldwide, irrevocable, transferable, exclusive license under
the Licensed Patents to make, have made, use, offer for sale, sell, and import
ophthalmic products or ophthalmic services solely in the ophthalmic field.

     C. BUYER and SELLER have entered into a Purchase and Sale Agreement
(defined below) to which this Agreement is an exhibit, and a Pledge and Security
Agreement (defined below), regarding the Assigned Patents.

     NOW, THEREFORE, in consideration of the premises, mutual promises and
covenants contained herein, the parties agree as follows:

I.   DEFINITIONS
     -----------

     For purposes of this Agreement, the following terms shall have the meanings
set forth below:

     A. "Purchase and Sale Agreement" shall mean that certain agreement between
BUYER and SELLER dated September 23, 2000, entitled "Purchase and Sale
Agreement."

     B. "Purchase Note" shall mean the Purchase Note referenced in the Purchase
and Sale Agreement.

     C. "Pledge and Security Agreement" shall mean that certain agreement
between BUYER and SELLER dated October 17, 2000, referenced in the Purchase and
Sale Agreement and entitled "Pledge and Security Agreement."

     D. "Assigned Patents" shall mean the patents and patent applications listed
in Exhibit B of the Purchase and Sale Agreement.

<PAGE>

     E. "Licensed Patents" shall mean the patents and patent applications listed
in Exhibit C of the Purchase and Sale Agreement.

     F. "BUYER's Field of Use" shall mean solely ophthalmic applications of
Erbium lasers.

II.  GRANT OF RIGHTS
     ---------------

     A. SELLER hereby assigns its entire right, title and interest in the
Assigned Patents to BUYER. SELLER agrees to execute a Patent Assignment attached
as Exhibit D-1.

     B. SELLER hereby grants to BUYER, and BUYER accepts a limited, worldwide,
irrevocable, transferable, exclusive license under the Licensed Patents to make,
have made, use, offer for sale, sell and import ophthalmic products or
ophthalmic services solely in BUYER's Field of Use.

     C. BUYER shall have the right to sublicense the rights provided to BUYER in
Section II.B of this Agreement.

III. OWNERSHIP
     ---------

     A. BUYER acknowledges that SELLER is the sole owner of the Licensed
Patents, and BUYER agrees that it does not obtain any interest in the Licensed
Patents except for the rights granted herein. BUYER agrees not to take any
action challenging or opposing, on any grounds whatsoever, the ownership by
SELLER of the Licensed Patents, or SELLER's intellectual property rights
therein. Furthermore, BUYER agrees not to contest the validity or
enforceability, or assist to request any third party to contest the validity or
enforceability of any of the Licensed Patents, to the extent and in
jurisdictions where permitted by law, in any judicial, governmental, or
quasi-governmental suit or proceeding; and not to request reexamination, or
assist or request any third party to request reexamination of any of the
Licensed Patents, to the extent and in jurisdictions where permitted by law.

IV.  TERM
     ----

     A. Unless sooner canceled or terminated as provided herein, the license
granted herein shall terminate on the expiration date of the last expiring of
the Licensed Patents.

V.   TERMINATION
     -----------

     A. This Agreement shall automatically and immediately terminate upon BUYERs
breach of any provision of the Purchase and Sale Agreement, the Purchase Note,
or the Pledge and Security Agreement.

     B. If any breach or default in respect of any of the terms of this
Agreement by either of the parties hereto shall occur, the other of said parties
shall have the right to provide written notice specifying in detail the nature
of the breach or default and if said alleged breach or default has, in fact,

<PAGE>

occurred and is not cured within sixty (60) days from the date of mailing of the
written notice, the other of said parties shall have the right to terminate this
Agreement upon giving an additional fifteen (15) days notice to the defaulting
party of its intent to terminate, and this Agreement shall terminate at the end
of such notice.

     C. For purposes of this Agreement, an event of default shall occur if (1)
BUYER or SELLER fails to perform any of their respective obligations hereunder,
or (2) BUYER becomes insolvent, or in financial difficulty, or the business of
BUYER is placed in the hands of a receiver or trustee, or an assignment is made
for the benefit of creditors of BUYER, if permitted by law.

     D. Upon any termination of this Agreement, BUYER shall make no further use
of any of the Licensed Patents.

     E. Certain provisions of this Agreement necessary to carry out the intent
of the parties, including, without limitation, Sections III, IX, X and XI shall
survive the termination or expiration of this Agreement.

VI.  PATENT MARKING
     --------------

     A. BUYER shall mark each product that is made, used, sold or imported
pursuant to the provisions herein with a patent notice in compliance with the
applicable statutory requirements.

VII. ENFORCEMENT OF RIGHTS
     ---------------------

     A. BUYER shall have the right, but not the obligation, to instigate any
lawsuit, at its own expense, to enforce the Licensed Patents in BUYER's Field of
Use.

     B. SELLER shall have the right, but not the obligation, to instigate any
lawsuit, at its own expense, to enforce the Licensed Patents outside BUYER's
Field of Use.

     C. Each party agrees to cooperate with and assist the other party, at the
other party's expense, in enforcing, protecting, and defending the Licensed
Patents, to the extent reasonably necessary, including but not limited to, being
joined as a necessary or desirable party to any legal proceedings.

VIII.PROSECUTION AND MAINTENANCE
     ---------------------------

     A. The entire patent process relating to procurement and maintenance of
Licensed Patents, including without limitation, prosecution of patent
applications and maintenance, reexamination, reissue, and extension of patents,
shall be in the sole control and at the sole discretion of SELLER. SELLER's sole
obligation with respect to the Licensed Patents shall be to prosecute currently
pending U.S. patent applications of the Licensed Patents until the U.S. Patent
and Trademark Office issues either a final rejection or a Notice of Allowance,

<PAGE>

whichever occurs first. Notwithstanding the foregoing, SELLER shall not be
required to file any additional patent applications in the U.S. or in any other
country.

IX.  NO WARRANTIES
     -------------

     A. Nothing in this Agreement shall be construed as a warranty or
representation that anything made, used, sold or otherwise disposed of under any
license granted in this Agreement is or will be free from infringement of
patents of third parties.

X.   INDEMNIFICATION
     ---------------

     BUYER hereby agrees to indemnify, defend, and hold SELLER harmless from and
against any and all claims, liability, loss, costs, damage or expense (including
attorneys' fees and costs) arising from or in any matter connected with: (i) the
infringement or alleged infringement of any third party rights resulting from
the manufacture or sale of BUYER's products or services; or (ii) the operation
of BUYER's business as it relates to this Agreement.

XI.  GENERAL PROVISIONS
     ------------------

     A. The parties hereby agree that this Agreement merely constitutes a
licensing agreement, and that no agency, joint venture or partnership is created
thereby, and that neither party shall incur obligations in the name of the other
party without said other party's prior written consent.

     B. Any notice, request, demand, statement or other writing required or
permitted by this Agreement shall be deemed sufficiently given to or made upon
the parties hereto when personally received, delivered by first class certified
or registered mail, postage prepaid, or delivered by overnight express courier
to the addresses set forth on the first page of this Agreement or such other
address of which the parties receive written notice.

     C. No failure or delay on the part of either party hereto in insisting upon
or enforcing or resorting to any of its powers, rights, remedies, or options
hereunder, and no partial or single exercise thereof, shall constitute a waiver
of any such powers, rights, remedies or options, unless such waiver be in
writing, signed by the party to be charged.

     D. If any provision of this Agreement should be held to be void or
unenforceable, in whole or in part, the court or tribunal so holding shall
reform the provision to make it enforceable while maintaining the spirit and
goal of the provision, and if the court or tribunal finds it cannot so reform
that provision, such provision or part thereof shall be treated as severable,
leaving valid the remainder of this Agreement.

     E. This Agreement, together with the Purchase and Sale Agreement to which
this Agreement is an Exhibit, including the Pledge and Security Agreement,
constitutes the entire understanding and agreement of the parties as to the
subject matter herein, and there are no representations, warranties, promises,
or undertakings other than those contained herein. As to the subject matter
hereof, this Agreement supersedes and cancels all previous agreements between

<PAGE>

the parties hereto. No course of conduct or dealing between the parties shall
act as a modification or waiver of any provision of this Agreement, and no
waiver or modification of any of the terms or provisions of this Agreement shall
be valid, unless contained in a single written document signed by both parties.

     F. This Agreement shall be binding upon the parties hereto and their
respective subsidiaries, affiliates, heirs, legal representatives, successors
and assigns.

     G. The headings in this Agreement are intended for convenience only, and
shall not be used to interpret the meaning of this Agreement or to determine the
rights of the parties.

     H. Each party shall perform any further acts and sign and deliver any
further documents that are reasonably necessary to effectuate the provisions of
the spirit of this Agreement.

                            [SIGNATURE PAGE FOLLOWS]

<PAGE>

         IN WITNESS  WHEREOF,  the parties  have caused  this  instrument  to be
executed, effective as of the day and year first above written.

                                            PREMIER LASER SYSTEMS, INC.
                                            ("SELLER")

Dated:        10/18/2000                    By:  /s/  Judith A. McCall
      -----------------------                  --------------------------------
                                                      Judith A. McCall

                                            Judith A. McCall
                                            -----------------------------------
                                            Printed Name

                                            Vice President HR & Admin
                                            -----------------------------------
                                            Title

                                            SURGILIGHT, INC.
                                            ("BUYER")

Dated:        10/18/2000                    By:  /s/  J.T. Lin
      -----------------------                  --------------------------------
                                                      J.T. Lin

                                            J. T. Lin
                                            -----------------------------------
                                            Printed Name

                                            President & CEO
                                            -----------------------------------
                                            Title

<PAGE>
<TABLE>
<CAPTION>

                                           EXHIBIT "C"

                                        LICENSED PATENTS

-----------------------------------------------------------------------------------------------
CASE NO            PATENT NO.    ISSUED        TITLE                                 COUNTRY
-----------------------------------------------------------------------------------------------
<S>                <C>          <C>            <C>                                  <C>
PREMLS.OOlFWI      5,116,329    5/26/92        Medical Laser Interconnect              USA
                                               System
-----------------------------------------------------------------------------------------------

PREMLS.001 VAU     612910       12/3/91        "                                    Australia
-----------------------------------------------------------------------------------------------
PREMLS.OO1VCA      2000916      1/17/95        "                                     Canada
-----------------------------------------------------------------------------------------------
PREMLS.001 VEP     0365228      12/14/94       "                                     Europe
-----------------------------------------------------------------------------------------------
PREMLS.OOlVFI      103322       6/15/99        "                                     Finland
-----------------------------------------------------------------------------------------------
PREMLS.041 VJP     3084029      6/30/00        "                                      Japan
-----------------------------------------------------------------------------------------------
PREMLS.OO1VN0      178842       6/19/96        "                                     Norway
-----------------------------------------------------------------------------------------------
PREMLS.001 VPT     92021        10/9/95        "                                    Portugal
-----------------------------------------------------------------------------------------------
PREMLS.002FW 1     5,207,673     5/4/93        Fiber Optic Apparatus for Use           USA
                                               With Medical Lasers
-----------------------------------------------------------------------------------------------
PREMLS.002VAU      613560       12/11/91       "                                    Australia
-----------------------------------------------------------------------------------------------
PREMLS.002VCA      2,018,450     5/9/95        "                                     Canada
-----------------------------------------------------------------------------------------------
PREMLS.002VKR      55974        11/2/92        "                                      Korea
-----------------------------------------------------------------------------------------------
PREMLS.009FW4      5,688,261    11/18/97       Transparent laser Surgical Probe        USA
-----------------------------------------------------------------------------------------------
PREMLS.O11FW4      5,707,368    1/13/98        Contact Tip For Laser Surgery           USA
-----------------------------------------------------------------------------------------------
PREMLS.018DV1      5,304,167    4/19/94        Multiwavelength Medical Laser           USA
                                               Method
-----------------------------------------------------------------------------------------------
PREMLS.050A        5,422,899     6/6/95        High Repetition rate Mid-               USA
                                               Infrared Laser
-----------------------------------------------------------------------------------------------
PREMLS.054VAU      685593        5/7/98        "                                    Australia
-----------------------------------------------------------------------------------------------
PREMLS.050VEP      0682389       9/2/98        "                                     Europe
-----------------------------------------------------------------------------------------------
PREMLS.050VIL      113501       5/19/97        High Pulse Repetition and Its         Israel
                                               Use
-----------------------------------------------------------------------------------------------
PREMLS.055FW3      5,722,970     3/3/98        Laser Surgical Method Using             USA
                                               Transparent Probe
-----------------------------------------------------------------------------------------------
PREMLS.O11DV1      6,110,167    8/29/00        Laser Surgical Probe                    USA
-----------------------------------------------------------------------------------------------
PREMLS.050DV2      6,122,300    9/19/00        High Repetition Rate Mid-               USA
                                               Infrared Laser
-----------------------------------------------------------------------------------------------

</TABLE>

<PAGE>
<TABLE>
<CAPTION>

                                   LICENSED PATENT APPLICATIONS

--------------------------------------------------------------------------------------------------
CASE NO            APPLICATION          FILED       TITLE                                COUNTRY
                       NO.
--------------------------------------------------------------------------------------------------
<S>                 <C>                <C>          <C>                                 <C>
PREMLS.OOl VDK      5185/89            10/19/89     Medical Laser Interconnect           Denmark
                                                    System
--------------------------------------------------------------------------------------------------
PREMLS.009DV 1      08/841,865          5/5/97      Laser Surgical Probe                   USA
--------------------------------------------------------------------------------------------------
PREMLS.009QCA       2107687             4/3/92      "                                    Canada
--------------------------------------------------------------------------------------------------
PREMLS.009QEP       92910340.6          4/3/92      "                                    Europe
--------------------------------------------------------------------------------------------------
PREMLS.050VCA       2148395             5/2/95      "                                    Canada
--------------------------------------------------------------------------------------------------
PREMLS.050VJP       110517/1995         5/9/95      Pulsed, Optically Pumped laser        Japan
                                                    and Surgical Method Using the
                                                    Same
--------------------------------------------------------------------------------------------------
PREMLS.050VKR       11234/1995          5/9/95      High Repetition Rate Mid-             Korea
                                                    Infrared Laser
--------------------------------------------------------------------------------------------------
PREMLS.081A         09/360,588         7/26/99      Single Dominant Spike Output           USA
                                                    Erbium Laser
--------------------------------------------------------------------------------------------------
PREMLS.081 VPC      PCT\US00\20241     7/26/00      "                                      PCT
--------------------------------------------------------------------------------------------------

</TABLE>

<PAGE>
<TABLE>
<CAPTION>

                                   EXHIBIT D-1

                                PATENT ASSIGNMENT

     WHEREAS, Premier Laser Systems, Inc., a California corporation (hereinafter
"ASSIGNOR"), hereby assigns its entire right, title, and interest to certain
United States issued Letters Patents and, applications for Letters Patents
(hereinafter "the Patents and Patent Applications") listed below:

------------------------- ------------ ------------------------------------------------ -----------------
 PATENT NO.               ISSUED       TITLE                                                COUNTRY
------------------------- ------------ ------------------------------------------------ -----------------
<S>                       <C>          <C>                                                   <C>
5,741,245                 4/21/98      Corneal Sculpting Using Laser Energy                   USA
------------------------- ------------ ------------------------------------------------ -----------------
5,738,677                 4/14/98      Apparatus & Method for Performing Eye                  USA
                                       Surgery
------------------------- ------------ ------------------------------------------------ -----------------
699994                    4/1/99       Apparatus & Method for Performing Eye               Australia
                                       Surgery
------------------------- ------------ ------------------------------------------------ -----------------
678967                    10/9/97      Apparatus & Method for Performing Eye               Australia
                                       Surgery
------------------------- ------------ ------------------------------------------------ -----------------
5,865,831                 2/2/99       Laser Surgical Procedures for Treatment of             USA
                                       Glaucoma
------------------------- ------------ ------------------------------------------------ -----------------

                               PATENT APPLICATIONS

----------------------------- ----------- ---------------------------------------------- ----------------
APPLICATION NO.               FILED       TITLE                                              COUNTRY
----------------------------- ----------- ---------------------------------------------- ----------------
<C>                           <C>         <C>                                                <C>
08/455899                     5/31/95     Corneal Sculpting Using Laser Energy                 US,
----------------------------- ----------- ---------------------------------------------- ----------------
93903487.2                    1/14/93     Corneal Sculpting Using Laser Energy               Europe
----------------------------- ----------- ---------------------------------------------- ----------------
513266/1993                   1/14/93     Corneal Sculpting Using Laser Energy                Japan
----------------------------- ----------- ---------------------------------------------- ----------------
09/018373                     2/4/98      Apparatus & Method for Performing Eye                USA
                                          Surgery
----------------------------- ----------- ---------------------------------------------- ----------------
2117765                       4/1/93      Apparatus & Method for Performing Eye              Canada
                                          Surgery
----------------------------- ----------- ---------------------------------------------- ----------------
93911621.6                    4/1/93      Apparatus & Method for Performing Eye              Europe
                                          Surgery
----------------------------- ----------- ---------------------------------------------- ----------------
518505/1993                   4/1/93      Apparatus & Method for Performing Eye               Japan
                                          Surgery
----------------------------- ----------- ---------------------------------------------- ----------------
94-703632                     4/1/93      Apparatus & Method for Performing Eye               Korea
                                          Surgery
----------------------------- ----------- ---------------------------------------------- ----------------
09/169258                     10/9/98     Laser Surgical Procedures For Treatment              USA
                                          of Glaucoma
----------------------------- ----------- ---------------------------------------------- ----------------

     WHEREAS, Surgilight, Inc., a Delaware corporation (hereinafter "ASSIGNEE")
desires to purchase ASSIGNOR's entire right, title, and interest in and to the
inventions disclosed in the Patents and Patent Applications;

</TABLE>

<PAGE>

     NOW, THEREFORE, in consideration of good and valuable consideration, the
receipt of which is hereby acknowledged, ASSIGNOR hereby further acknowledges
that it has sold, assigned, and transferred, and by these presents does hereby
sell, assign, and transfer, unto ASSIGNEE, its successors, legal
representatives, and assigns, ASSIGNOR's entire right, title, and interest
throughout the world in, to, and under the said improvements, and the said
Patents and Patent Applications and all Patents that may be granted thereon, and
all divisions, continuations, reissues, reexaminations, renewals, and extensions
thereof, and all rights of priority under International Conventions and
applications for Letters Patent that may hereafter be filed for said
improvements or for the said Patents and Patent Applications in any country or
countries foreign to the United States; and ASSIGNOR hereby authorizes and
requests the Commissioner. of Patents of the United States, and any Official of
any country foreign to the United States, whose duty it is to issue patents on
applications as aforesaid, to issue all Letters Patents for said improvements
and all Letters Patents resulting from the Patents and Patent Applications to
ASSIGNEE, its successors, legal representatives, and assigns, in accordance with
the terms of this Agreement.

     ASSIGNOR does hereby sell, assign, transfer, and convey to ASSIGNEE, its
successors, legal representatives, and assigns all claims for damages and all
remedies arising out of any violation of the rights assigned hereby that may
have accrued prior to the date of assignment to ASSIGNEE, or may accrue
hereafter, including, but not limited to, the right to sue for, collect, and
retain damages for past infringements of the said issued Letters Patents.

                            [SIGNATURE PAGE FOLLOWS]

<PAGE>

     IN TESTIMONY WHEREOF, I hereunto set my hand and seal this ____ day of
_________________, 20__.

                                            PREMIER LASER SYSTEMS, INC.

                                            By:
                                               --------------------------------

                                            Name Printed:
                                                         ----------------------

                                            Title:
                                                  -----------------------------

                                            Date:
                                                 ------------------------------

STATE OF              )

COUNTY OF             )

     On ___________________, 20__, before me, personally appeared
__________________________ personally known to me (or proved to me on the basis
of satisfactory evidence) to be the person(s) whose name is subscribed to the
within instrument, and acknowledged to me that he/she executed the same in
his/her authorized capacity and that by his/her signature on the instrument the
person, or the entity upon behalf of which the person acted, executed the
instrument.

     WITNESS my hand and official seal.

[SEAL]
                                            -----------------------------------
                                            Notary Signature

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00023-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00023-of-00352.parquet"}]]